Literature DB >> 25296556

RS11212617 is associated with metformin treatment response in type 2 diabetes in Shanghai local Chinese population.

Y Zhou1, Y Guo, W Ye, Y Wang, X Li, Y Tian, Z Liu, S Li, J Yan.   

Abstract

OBJECTIVE: This study was designed to examine the relevance of single-nucleotide polymorphism (SNP) rs11212617 with treatment success in type 2 diabetes patients from Shanghai local Chinese Han population.
METHODS: We genotyped rs11212617 in incident metformin users of type 2 diabetes patients from Shanghai local Chinese Han population. Association between rs11212617 and changes in HbA1c, fasting plasma glucose and postprandial glucose level were analysed.
RESULTS: Two hundred and seventy-four incident metformin users were included in the study sample. The SNP rs11212617 was significantly associated with metformin response in Shanghai local Chinese Han population.
CONCLUSION: The rs11212617 is associated with a reduction in HbA1c, fasting plasma glucose and postprandial glucose level. These results suggest that metformin treatment may be more efficacious in Shanghai and valuable for Chinese daily clinical practice.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296556     DOI: 10.1111/ijcp.12534

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  10 in total

Review 1.  Genetics of drug response in type 2 diabetes.

Authors:  Ivan Tkáč
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

2.  Genetic variants of OCT1 influence glycemic response to metformin in Han Chinese patients with type-2 diabetes mellitus in Shanghai.

Authors:  Yong Zhou; Weiwei Ye; Yi Wang; Zhikui Jiang; Xiangying Meng; Qian Xiao; Qian Zhao; Jian Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups.

Authors:  Moataz E Mohamed; David P Schladt; Weihua Guan; Baolin Wu; Jessica van Setten; Brendan J Keating; David Iklé; Rory P Remmel; Casey R Dorr; Roslyn B Mannon; Arthur J Matas; Ajay K Israni; William S Oetting; Pamala A Jacobson
Journal:  Am J Transplant       Date:  2019-05-13       Impact factor: 8.086

Review 4.  Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery.

Authors:  Kaixin Zhou; Helle Krogh Pedersen; Adem Y Dawed; Ewan R Pearson
Journal:  Nat Rev Endocrinol       Date:  2016-04-11       Impact factor: 43.330

Review 5.  Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents.

Authors:  Adem Yesuf Dawed; Kaixin Zhou; Ewan Robert Pearson
Journal:  Pharmgenomics Pers Med       Date:  2016-04-06

6.  SLC22A1 rs622342 Polymorphism Predicts Insulin Resistance Improvement in Patients with Type 2 Diabetes Mellitus Treated with Metformin: A Cross-Sectional Study.

Authors:  Kunrong Wu; Xiaoli Li; Yuedong Xu; Xiaoqian Zhang; Ziwan Guan; Shufang Zhang; Yan Li
Journal:  Int J Endocrinol       Date:  2020-05-08       Impact factor: 3.257

7.  SLC22A1 And ATM Genes Polymorphisms Are Associated With The Risk Of Type 2 Diabetes Mellitus In Western Saudi Arabia: A Case-Control Study.

Authors:  Rana M Altall; Safaa Y Qusti; Najlaa Filimban; Amani M Alhozali; Najat A Alotaibi; Ashraf Dallol; Adeel G Chaudhary; Sherin Bakhashab
Journal:  Appl Clin Genet       Date:  2019-11-15

8.  Genetic and Phenotypic Factors Affecting Glycemic Response to Metformin Therapy in Patients with Type 2 Diabetes Mellitus.

Authors:  Yulia A Nasykhova; Yury A Barbitoff; Ziravard N Tonyan; Maria M Danilova; Ivan A Nevzorov; Tatiana M Komandresova; Anastasiia A Mikhailova; Tatiana V Vasilieva; Olga B Glavnova; Maria I Yarmolinskaya; Evgenia I Sluchanko; Andrey S Glotov
Journal:  Genes (Basel)       Date:  2022-07-23       Impact factor: 4.141

Review 9.  Personalized medicine in diabetes: the role of 'omics' and biomarkers.

Authors:  E R Pearson
Journal:  Diabet Med       Date:  2016-06       Impact factor: 4.359

Review 10.  Pharmacogenetics of Type 2 Diabetes-Progress and Prospects.

Authors:  Yulia A Nasykhova; Ziravard N Tonyan; Anastasiia A Mikhailova; Maria M Danilova; Andrey S Glotov
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.